Velosulin Articles
Lilly pulls out of inhaled insulin development
17 March 2008
Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%
4 February 2008
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
Exubera shows safety and efficacy
7 February 2007
Exubera use not complicated by respiratory infections
25 September 2006
Emerging diabetes management solutions boost European market
14 August 2006
NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals
24 April 2006
Novo Nordisk's recombinant Velosulin OKed in USA
27 July 1999
Showing 1-8 of 8 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
